endometrial cancer

Repare Therapeutics eyes Phase III cancer study after Mythic trial success
Clinical Trials Arena
Fri, 12/13/24 - 11:48 am
Repare Therapeutics
clinical trials
endometrial cancer
ovarian cancer
Lunre+Camo
AstraZeneca’s Imfinzi-Lynparza Combo Wins Landmark EU Nod for Endometrial Cancer
BioSpace
Wed, 08/14/24 - 10:58 am
AstraZeneca
Europe
Imfinzi
Lynparza
endometrial cancer
GSK blows Jemperli marching brass against Keytruda with expanded FDA nod in endometrial cancer
Fierce Pharma
Thu, 08/1/24 - 11:19 pm
GSK
Jemperli
Merck
Keytruda
FDA
endometrial cancer
Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval
Fierce Pharma
Tue, 06/18/24 - 11:40 am
Merck
Keytruda
endometrial cancer
GSK
FDA
AstraZeneca Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer
Reuters
Mon, 06/17/24 - 11:31 am
AstraZeneca
Imfinzi
endometrial cancer
FDA
Keytruda strikes out again in endometrial cancer with phase III flop
BioSpace
Thu, 05/9/24 - 11:49 am
Merck
Keytruda
clinical trials
endometrial cancer
Rubraca sheds positive light for PARP inhibitors in endometrial cancer
Clinical Trials Arena
Tue, 04/2/24 - 11:43 am
Rubraca
Clovis Oncology
endometrial cancer
clinial trials
AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need
BioSpace
Mon, 03/18/24 - 05:19 pm
AstraZeneca
Lynparza
Imfinzi
endometrial cancer
GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data
BioSpace
Mon, 03/18/24 - 05:11 pm
GSK
Jemperli
endometrial cancer
GSK's cancer drug combination meets primary goal in late-stage trial
Reuters
Mon, 12/18/23 - 10:10 am
GSK
Zejula
Jemperli
endometrial cancer
clinical trials
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
Reuters
Fri, 12/8/23 - 09:59 am
Merck
Eisai
4523.T
clinical trials
endometrial cancer
Keytruda
Lenvima
GSK's Jemperli prolongs life in endometrial cancer trial. Will FDA label expansion come next?
Fierce Pharma
Mon, 10/30/23 - 10:12 am
GSK
Jemperli
endometrial cancer
clinical trials
ESMO: AstraZeneca proposes adding Lynparza to Imfinzi as endometrial cancer race heats up
Fierce Pharma
Mon, 10/23/23 - 09:07 am
ESMO
AstraZeneca
Merck
Lynparza
endometrial cancer
GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer
Fierce Pharma
Mon, 07/31/23 - 09:59 pm
GSK
FDA
immunotherapy
endometrial cancer
Jemperli
AstraZeneca reports positive results from endometrial cancer therapy trial
Clinical Trials Arena
Mon, 05/29/23 - 12:24 pm
AstraZeneca
endometrial cancer
clinical trials
Imfinzi
Lynparza
AstraZeneca's drug combo shows positive results in late-stage cancer trial
Reuters
Fri, 05/26/23 - 10:09 am
ASCO 2023
AstraZeneca
Imfinzi
Lynparza
endometrial cancer
Merck Eyes Third Endometrial Cancer Nod for Keytruda
BioSpace
Fri, 02/3/23 - 10:30 am
Merck
Keyruda
clinical trials
endometrial cancer
GSK Notches Phase III Win for Jemperli in Endometrial Cancer
BioSpace
Sun, 12/4/22 - 01:13 pm
GSK
Jemperli
clinical trials
endometrial cancer
A startup plans an IPO to give a shelved Lilly drug another shot
BioPharma Dive
Wed, 10/19/22 - 10:39 am
Acrivon Therapeutics
IPOs
Eli Lilly
prexasertib
ovarian cancer
endometrial cancer
bladder cancer
precision medicine
Could This FDA Approval Be a Boost for Merck?
Motley Fool
Thu, 04/28/22 - 11:04 am
Merck
Keytruda
FDA
endometrial cancer

Pages